Oppenheimer Asset Management Inc. Boston Scientific Corp Transaction History

Oppenheimer Asset Management Inc.

  • $8.04 Billion
  • Q3 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 114,266 shares of BSX stock, worth $10.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
114,266
Previous 115,651 1.2%
Holding current value
$10.3 Million
Previous $8.91 Million 7.51%
% of portfolio
0.12%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$72.96 - $84.0 $101,049 - $116,340
-1,385 Reduced 1.2%
114,266 $9.58 Million
Q2 2024

Aug 08, 2024
BUY
$67.33 - $77.71 $1.02 Million - $1.18 Million
15,216 Added 15.15%
115,651 $8.91 Million
Q1 2024

May 06, 2024
SELL
$57.6 - $68.62 $470,937 - $561,037
-8,176 Reduced 7.53%
100,435 $6.88 Million
Q4 2023

Feb 13, 2024
SELL
$48.64 - $57.81 $84,876 - $100,878
-1,745 Reduced 1.58%
108,611 $6.28 Million
Q3 2023

Nov 07, 2023
BUY
$50.19 - $54.68 $3.87 Million - $4.21 Million
77,051 Added 231.35%
110,356 $5.83 Million
Q2 2023

Aug 02, 2023
SELL
$49.72 - $54.64 $651,779 - $716,275
-13,109 Reduced 28.24%
33,305 $1.8 Million
Q1 2023

May 10, 2023
SELL
$45.09 - $50.03 $43,647 - $48,429
-968 Reduced 2.04%
46,414 $2.32 Million
Q4 2022

Feb 06, 2023
BUY
$39.56 - $47.22 $280,045 - $334,270
7,079 Added 17.56%
47,382 $2.19 Million
Q3 2022

Nov 14, 2022
SELL
$36.71 - $109.66 $2,606 - $7,785
-71 Reduced 0.18%
40,303 $1.56 Million
Q2 2022

Aug 08, 2022
SELL
$35.24 - $47.1 $30,447 - $40,694
-864 Reduced 2.1%
40,374 $1.51 Million
Q1 2022

May 12, 2022
SELL
$40.9 - $45.1 $28,466 - $31,389
-696 Reduced 1.66%
41,238 $1.83 Million
Q4 2021

Feb 02, 2022
SELL
$38.07 - $44.87 $129,247 - $152,333
-3,395 Reduced 7.49%
41,934 $1.78 Million
Q3 2021

Nov 12, 2021
BUY
$41.23 - $45.88 $1.18 Million - $1.31 Million
28,627 Added 171.4%
45,329 $1.97 Million
Q2 2021

Aug 03, 2021
BUY
$38.58 - $44.24 $2,083 - $2,388
54 Added 0.32%
16,702 $715,000
Q1 2021

May 17, 2021
SELL
$35.27 - $39.67 $32,448 - $36,496
-920 Reduced 5.24%
16,648 $643,000
Q4 2020

Feb 11, 2021
SELL
$33.15 - $41.97 $1.27 Million - $1.6 Million
-38,161 Reduced 68.48%
17,568 $631,000
Q3 2020

Nov 13, 2020
BUY
$34.44 - $42.23 $71,807 - $88,049
2,085 Added 3.89%
55,729 $2.13 Million
Q2 2020

Aug 11, 2020
SELL
$30.19 - $39.11 $447,144 - $579,258
-14,811 Reduced 21.64%
53,644 $1.88 Million
Q1 2020

May 08, 2020
BUY
$25.83 - $45.71 $378,900 - $670,519
14,669 Added 27.27%
68,455 $2.23 Million
Q4 2019

Feb 07, 2020
BUY
$37.87 - $45.37 $34,840 - $41,740
920 Added 1.74%
53,786 $2.43 Million
Q3 2019

Oct 31, 2019
BUY
$40.31 - $43.45 $289,022 - $311,536
7,170 Added 15.69%
52,866 $2.15 Million
Q2 2019

Aug 09, 2019
BUY
$34.91 - $42.98 $4,503 - $5,544
129 Added 0.28%
45,696 $1.96 Million
Q1 2019

Apr 24, 2019
BUY
$32.91 - $40.75 $186,106 - $230,441
5,655 Added 14.17%
45,567 $1.75 Million
Q4 2018

Jan 30, 2019
SELL
$31.73 - $39.04 $2,125 - $2,615
-67 Reduced 0.17%
39,912 $1.41 Million
Q3 2018

Oct 26, 2018
BUY
$32.83 - $38.63 $51,050 - $60,069
1,555 Added 4.05%
39,979 $1.54 Million
Q2 2018

Aug 10, 2018
BUY
$26.84 - $34.32 $5,099 - $6,520
190 Added 0.5%
38,424 $1.26 Million
Q1 2018

May 09, 2018
BUY
$25.2 - $28.54 $54,003 - $61,161
2,143 Added 5.94%
38,234 $1.04 Million
Q3 2017

Nov 14, 2017
BUY
$26.26 - $29.17 $947,749 - $1.05 Million
36,091
36,091 $1.05 Million

Others Institutions Holding BSX

# of Institutions
1,543
Shares Held
1.19B
Call Options Held
6.79M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email